Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novartis AG (NVS) vs Realty Income Corp (O) Price & Performance

Novartis AGTrade
Realty Income CorpTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Realty Income Corp — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Realty Income Corp trades at $64.95 (market cap $60.78B). The key difference: Novartis AG is far larger — about 4.8× Realty Income Corp's market cap, and Realty Income Corp pays the higher dividend (4.99%). Which is the better fit depends on your goals.

NVSO
Market Cap
$290.25B$60.78B
Sector
HealthReal Estate
52-Week High
$168.62$67.56
52-Week Low
$113.50$55.93
Enterprise Value
$330.27B$90.58B
Dividend Yield
3.17%4.99%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS

About Realty Income Corp

Realty Income owns roughly 11,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, office, manufacturing, and distribution properties, which make up roughly 17% of revenue.

Read more on O